158 related articles for article (PubMed ID: 25401297)
81. Chronic myeloid leukemia with a novel e8a1 BCR-ABL1 fusion: rapid molecular response with nilotinib.
Crampe M; Shakkak F; Kelly J; Hodgson A; Langabeer SE
Leuk Lymphoma; 2017 Sep; 58(9):1-6. PubMed ID: 28121203
[No Abstract] [Full Text] [Related]
82. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance.
Kantarjian HM; Giles F; Gattermann N; Bhalla K; Alimena G; Palandri F; Ossenkoppele GJ; Nicolini FE; O'Brien SG; Litzow M; Bhatia R; Cervantes F; Haque A; Shou Y; Resta DJ; Weitzman A; Hochhaus A; le Coutre P
Blood; 2007 Nov; 110(10):3540-6. PubMed ID: 17715389
[TBL] [Abstract][Full Text] [Related]
83. BCR/ABL rearrangement and leukemia phenotype.
Saglio G; Pane F; Martinelli G; Guerrasio A
Leukemia; 1999 Apr; 13 Suppl 1():S96. PubMed ID: 10232378
[No Abstract] [Full Text] [Related]
84. Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
Hackanson B; Rückert A; Lübbert M
Eur J Haematol; 2009 Dec; 83(6):611-2. PubMed ID: 19682063
[No Abstract] [Full Text] [Related]
85. Philadelphia chromosome-positive acute myeloid leukemia (Ph + AML) treated with imatinib mesylate (IM): a report with IM plasma concentration and bcr-abl transcripts.
Kondo T; Tasaka T; Sano F; Matsuda K; Kubo Y; Matsuhashi Y; Nakanishi H; Sadahira Y; Wada H; Sugihara T; Tohyama K
Leuk Res; 2009 Sep; 33(9):e137-8. PubMed ID: 19371951
[TBL] [Abstract][Full Text] [Related]
86. Combination therapy with nilotinib for drug-sensitive and drug-resistant BCR-ABL-positive leukemia and other malignancies.
Weisberg E; Nonami A; Griffin JD
Arch Toxicol; 2014 Dec; 88(12):2233-42. PubMed ID: 25331939
[TBL] [Abstract][Full Text] [Related]
87. ABL-specific tyrosine kinase inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome-positive acute mixed lineage leukemia (AMLL).
Selle B; Bär C; Hecker S; Schmidt-Rohr U; Viehmann S; Debatin KM; Reinhardt D
Leukemia; 2002 Jul; 16(7):1393-5. PubMed ID: 12094266
[No Abstract] [Full Text] [Related]
88. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.
Ninomiya S; Kanemura N; Tsurumi H; Kasahara S; Hara T; Yamada T; Moriwaki H
Int J Hematol; 2011 Jun; 93(6):806-810. PubMed ID: 21523337
[TBL] [Abstract][Full Text] [Related]
89. Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.
Schmidt M; Rinke J; Schäfer V; Schnittger S; Kohlmann A; Obstfelder E; Kunert C; Ziermann J; Winkelmann N; Eigendorff E; Haferlach T; Haferlach C; Hochhaus A; Ernst T
Leukemia; 2014 Dec; 28(12):2292-9. PubMed ID: 25212276
[TBL] [Abstract][Full Text] [Related]
90. Concurrent
Salter B; Ge S; Tam A; Demczuk S; Butcher D; McCready E; Khalaf D
EJHaem; 2024 Jun; 5(3):607-615. PubMed ID: 38895060
[TBL] [Abstract][Full Text] [Related]
91. Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia.
Manley R; Cochrane J; McDonald M; Rigby S; Moore A; Kirk A; Clarke S; Crossen PE; Morris CM; Patton WN
Leukemia; 1999 Jan; 13(1):126-9. PubMed ID: 10049047
[TBL] [Abstract][Full Text] [Related]
92. [Detection of BCR-ABL1 chimeric gene-positive neutrophils in a patient with mixed phenotype acute leukemia].
Nagasawa F; Nakamura Y; Tokita K; Takahashi W; Iso H; Arai H; Tsurumi S; Handa T; Nakamura Y; Nakamura Y; Sasaki K; Mitani K
Rinsho Ketsueki; 2013 Nov; 54(11):2074-8. PubMed ID: 24305542
[TBL] [Abstract][Full Text] [Related]
93. Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study.
Kizilors A; Crisà E; Lea N; Passera R; Mian S; Anwar J; Best S; Nicolini FE; Ireland R; Aldouri M; Pocock C; Corbett T; Gale R; Bart-Smith E; Weston-Smith S; Wykes C; Kulasekararaj A; Jackson S; Harrington P; McLornan D; Raj K; Pagliuca A; Mufti GJ; de Lavallade H
Lancet Haematol; 2019 May; 6(5):e276-e284. PubMed ID: 31036317
[TBL] [Abstract][Full Text] [Related]
94. Emergence of a BCR::ABL1 rearrangement following a uniquely complex clonal evolution pattern in a patient undergoing Fms-like tyrosine kinase 3 inhibitor therapy for acute myeloid leukemia.
Park B; Kim J; Kim M; Cho YU; Hwang SH; Jang S; Seo EJ; Choi EJ; Park CJ
Int J Lab Hematol; 2023 Apr; 45(2):e24-e27. PubMed ID: 36180046
[No Abstract] [Full Text] [Related]
95. Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome.
Kurt H; Zheng L; Kantarjian HM; Tang G; Ravandi-Kashani F; Garcia-Manero G; Gong Z; Amin HM; Konoplev SN; Routbort MJ; Han X; Wang W; Medeiros LJ; Hu S
Mod Pathol; 2018 Jul; 31(7):1141-1154. PubMed ID: 29449681
[TBL] [Abstract][Full Text] [Related]
96. Emergence of
Kim H; Kim IS; Kim H
Ann Lab Med; 2023 Jul; 43(4):386-388. PubMed ID: 36843408
[No Abstract] [Full Text] [Related]
97. Longitudinal clonal architecture of acute myeloid leukemia with
Gallego Hernanz MP; Sorel N; Bouyer S; Desmier D; Chollet M; Maillard N; Brizard F; Moya N; Diaz JMT; Leleu X; Chomel JC
Leuk Lymphoma; 2020 Jul; 61(7):1709-1713. PubMed ID: 32077355
[No Abstract] [Full Text] [Related]
98. Multiple erythrophagocytosis by erythroid blasts in acute myeloid leukemia with BCR-ABL1.
Mellado-Gázquez Á; Gómez-Núñez MR; Jurado-Herrera S; Prats-Martín C; Caballero-Velázquez T; Morales-Camacho RM
Ann Hematol; 2022 Jun; 101(6):1375-1377. PubMed ID: 35083526
[No Abstract] [Full Text] [Related]
99. Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis.
Brattås MK; Lilleeng K; Hovland R; Lægreid IJ; Vorland M; Leh F; Bruserud Ø; Gjertsen BT; Reikvam H
Biomark Res; 2018; 6():33. PubMed ID: 30479769
[TBL] [Abstract][Full Text] [Related]
100. An interesting case of chronic myeloid leukemia (CML) with T315I mutation raising suspicion of de novo AML, a diagnostic conundrum.
Iqbal P; Shahzad A; Shahid Z; Ghori F; Elomri H; Soliman D
Clin Case Rep; 2023 May; 11(5):e5908. PubMed ID: 37234472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
